Lilly bags Reyvow FDA approval for acute treatment of migraine

pharmanewsdaily- October 13, 2019 0

Reyvow FDA approval : Eli Lilly and Company (Lilly) has bagged approval from the US Food and Drug Administration (FDA) for Reyvow (lasmiditan) for the ... Read More